Always keep an eye on insider buying.
After all, it’s the insiders that know their company the best. And if they’re putting their money where their mouths are, that’s telling.
Here are just a few stocks worth watching thanks to recent insider activity.
|
Company: Agree Realty (SYM: ADC) A real estate investment trust with a yield of 4.51%, Agree Realty (SYM: ADC) acquires and develops properties net leased to industry-leading, omnichannel retail tenants. As of March 31, the REIT owned and operated a portfolio of 2,161 properties, located in 49 states and containing approximately 44.9 million square feet of gross leasable area. Director John Rakolta Jr. recently bought another 20,000 shares for just over $1.18 million. Prior to this buy, he bought 20,102 shares for $1.14 million in February, and 20,430 shares for $1.164 million in February as well. |
Traders Agency
Out of this World AI Profits (2,490X potential!)
Who’s going to come out on top in the AI war?
A big tech titan like Microsoft and Google…
Or another big player with substantial bets on the technology, like International Business Machines (IBM), Nvidia (NVDA), or Advanced Micro Devices (AMD)?
NOPE. None of the above!
WATCH MY VIDEO BULLETIN NOW.
|
Company: Biohaven (SYM: BHVN) Biohaven is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Director John Childs recently bought 28,400 shares of the stock for about $1.01 million. After pulling back from about $60 to $36, the stock is starting to show signs of life again. From its last traded price of $36.13, we’d like to see it retest $50 near term. |
Weiss Ratings
Modern Nostradamus Warns of Financial Disaster Pre-Election
Dr. Martin Weiss, who has predicted past financial crises with deadly accuracy, now warns of a major catastrophe that could begin before the next election. Millions could lose their savings, their investments, their financial freedom. But just taking three vital steps now can safeguard your future.
Watch Dr. Weiss’s urgent video to discover how to shield yourself from the impending crisis!
|
Company: Adverum Biotechnologies (SYM: ADVM) The company, which targets unmet medical needs for serious ocular and rare diseases, including wet age-related macular degeneration just saw a significant shareholder buy 216,264 shares for just over $1.785 million. |
